Document is current
Any future updates will be listed below
-
Authors
Stocchi, Fabrizio https://orcid.org/0000-0002-5763-0033
Bravi, Daniele
Emmi, Aron https://orcid.org/0000-0002-2796-5676
Antonini, Angelo
- License Information
-
More Information
Article History
Accepted: 8 October 2024
First Online: 4 November 2024
Competing interests
: F.S. has received compensation for consultancy and speaker-related activities from UCB, Britannia, AbbVie, Zambon, Bial, Ever Pharma, Synegile, Biogen, Roche, Blue Rock, Chiesi Pharmaceuticals, Lundbeck, Sunovion and Kiowa. D.B. is a business partner of SixDegrees HealthCare and has received fees from Clexio, Herantis, Theravance, Novartis and PPD. A.A. has received compensation for consultancy and speaker-related activities from UCB, Britannia, AbbVie, Zambon, Bial, Ever Pharma, Ferrer, Theravance Biopharma, Bayer, TreeFrog Therapeutics, Oligy and Medscape. He receives research support from Lundbeck, Bial, Movement Disorders Society, Horizon2020 Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081 and Fondazione Grigioni per la Malattia di Parkinson. A.E. declares no competing interests.
